HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Thomas E Muerdter Selected Research

N,N-didesmethyl-4-hydroxytamoxifen

1/2016Association of CYP2C19*2 and associated haplotypes with lower norendoxifen concentrations in tamoxifen-treated Asian breast cancer patients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Thomas E Muerdter Research Topics

Disease

3Breast Neoplasms (Breast Cancer)
10/2016 - 06/2007
1Neoplasms (Cancer)
06/2007

Drug/Important Bio-Agent (IBA)

2TamoxifenFDA LinkGeneric
10/2016 - 01/2016
1Cytochrome P-450 CYP2C19IBA
01/2016
1N,N-didesmethyl-4-hydroxytamoxifenIBA
01/2016
1Pharmaceutical PreparationsIBA
06/2007
1Fluorouracil (Carac)FDA LinkGeneric
06/2007
1Docetaxel (Taxotere)FDA Link
06/2007
1Epirubicin (Ellence)FDA LinkGeneric
06/2007
1Biomarkers (Surrogate Marker)IBA
06/2007
1AnthracyclinesIBA
06/2007
1CaspasesIBA
06/2007
1Keratin-18 (Keratin 18)IBA
06/2007
1Cyclophosphamide (Cytoxan)FDA LinkGeneric
06/2007

Therapy/Procedure

1Drug Therapy (Chemotherapy)
06/2007
1Therapeutics
06/2007